Diferencia entre revisiones de «Alpha blockers»
(Text replacement - "α 2" to "α<sub>2</sub>") |
Sin resumen de edición |
||
| (No se muestran 3 ediciones intermedias de 3 usuarios) | |||
| Línea 1: | Línea 1: | ||
==Background== | ==Background== | ||
*Also known as α-blockers | *Also known as α-blockers | ||
** | **α<sub>1</sub>-blockers act on α<sub>1</sub>-adrenoceptors | ||
** | **α<sub>2</sub>-blockers act on α<sub>2</sub>-adrenoceptors | ||
*Act as neutral antagonists or inverse agonists of | *Act as neutral antagonists or inverse agonists of α-adrenergic receptors (α-adrenoceptors) | ||
==Medications== | ==Medications== | ||
| Línea 13: | Línea 13: | ||
*Typical and atypical [[antipsychotics]] | *Typical and atypical [[antipsychotics]] | ||
===Selective α 1=== | ===Selective α<sub>1</sub>=== | ||
*[[Alfuzosin]] | *[[Alfuzosin]] | ||
*[[Doxazosin]] | *[[Doxazosin]] | ||
| Línea 32: | Línea 32: | ||
==Uses== | ==Uses== | ||
*[[hypertension]] | *[[hypertension]] | ||
*[[ | *[[Raynaud’s disease]] | ||
*[[scleroderma]] | *[[scleroderma]] | ||
*[[generalized anxiety disorder]] | *[[generalized anxiety disorder]] | ||
| Línea 42: | Línea 42: | ||
*[[Antihypertensive medications]] | *[[Antihypertensive medications]] | ||
*[[Beta blocker]] | *[[Beta blocker]] | ||
*[[Yohimbine toxicity]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Revisión actual - 14:28 19 oct 2019
Background
- Also known as α-blockers
- α1-blockers act on α1-adrenoceptors
- α2-blockers act on α2-adrenoceptors
- Act as neutral antagonists or inverse agonists of α-adrenergic receptors (α-adrenoceptors)
Medications
Non-selective
- Phenoxybenzamine
- Phentolamine
- Tolazoline
- Trazodone
- Typical and atypical antipsychotics
Selective α1
Selective α2
Mixed
- The agents carvedilol and labetalol are both α- and β-blockers.
Uses
- hypertension
- Raynaud’s disease
- scleroderma
- generalized anxiety disorder
- panic disorder
- posttraumatic stress disorder
- benign prostatic hyperplasia